LARA MORGAN: Open Payments
NPI 1578899043 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,857 in 92 payments from 24 companies in 2025. Trend: 2023 $2,787 · 2024 $2,575 · 2025 $1,857
Food & beverage: $1,838Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $280 |
| Otsuka America Pharmaceutical, Inc. | 13 | $222 |
| PFIZER INC. | 14 | $212 |
| AstraZeneca Pharmaceuticals LP | 8 | $160 |
| Sumitomo Pharma America, Inc. | 5 | $129 |
| Amgen Inc. | 5 | $88 |
| GlaxoSmithKline, LLC. | 3 | $85 |
| Lilly USA, LLC | 5 | $79 |
| Merck Sharp & Dohme LLC | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $66 |
Products named: REXULTI, GEMTESA, VRAYLAR, EVENITY, UBRELVY, NURTEC ODT, ZAVZPRET, CAPLYTA.
Industry payments across CO — which companies pay providers there.
